Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human Reelin ELISA Kit (AC2651)
Cat.#: ASET-1240
Specifications
Description Human Reelin ELISA Kit allows for the in vitro quantitative determination of human Reelin concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 9.375 pg/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 15.625-1000 pg/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1689 Human GABA A Receptor alpha 1 ELISA Kit (AC3100) Quantitative inquiry ASET-1444 Human SorCS1 ELISA Kit (AC2855) Quantitative inquiry ASET-2073 Human P2Y2 ELISA Kit (AC3484) Quantitative inquiry ASET-2422 Human SHARP1 ELISA Kit (AC3833) Quantitative inquiry ASET-1647 Mouse Wnt3a ELISA Kit (AC3058) Quantitative inquiry ASET-1400 Mouse Semaphorin 3A ELISA Kit (AC2811) Quantitative inquiry ASET-2152 Human FGF19 ELISA Kit (AC3563) Quantitative inquiry ASET-2128 Human Chromogranin A ELISA Kit (AC3539) Quantitative inquiry ASET-1669 Mouse Cathepsin G ELISA Kit (AC3080) Quantitative inquiry ASET-2439 Human PON3 ELISA Kit (AC3850) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket